Juli Miller | Senior Director, IR |
Adrian Rawcliffe | CEO |
Elliot Norry | Senior VP and Chief Medical Officer |
Helen Tayton-Martin | Co-Founder and Chief Business Officer |
Tony Butler | ROTH Capital |
Kenneth Atkins | Cowen & Company |
Mohit Bansal | Citi Group |
Michael Smith | Guggenheim |
Nick Abbott | Wells Fargo |
Ladies and gentlemen, thank you for standing by and welcome to Adaptimmune Conference Call. With that I will turn the call over to Juli Miller. Ma'am you may begin.
Good morning and welcome to Adaptimmune's conference call to discuss our full year and fourth quarter 2020 financial results and business update. I would ask you to please review the full text of our forward-looking statements from this morning's press release.